MARKET

STRO

STRO

Sutro Biopharma
NASDAQ
23.26
-0.75
-3.12%
Opening 10:53 07/28 EDT
OPEN
24.15
PREV CLOSE
24.01
HIGH
24.19
LOW
22.83
VOLUME
78.58K
TURNOVER
--
52 WEEK HIGH
43.85
52 WEEK LOW
7.15
MARKET CAP
385.43M
P/E (TTM)
-1.4222
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at STRO last week (0720-0724)?
Weekly Report · 1d ago
Weekly Report: what happened at STRO last week (0713-0717)?
Weekly Report · 07/20 09:20
Weekly Report: what happened at STRO last week (0706-0710)?
Weekly Report · 07/13 09:21
Aura Biosciences appoints Jeremy Bender to board of directors
PUBT · 07/08 11:04
Weekly Report: what happened at STRO last week (0629-0703)?
Weekly Report · 07/06 09:22
Weekly Report: what happened at STRO last week (0622-0626)?
Weekly Report · 06/29 09:20
Barclays Sticks to Its Buy Rating for Sutro Biopharma (STRO)
TipRanks · 06/23 08:57
Weekly Report: what happened at STRO last week (0615-0619)?
Weekly Report · 06/22 09:23
More
About STRO
Sutro Biopharma, Inc. is an oncology company engaged in developing site-specific and novel-format antibody drug conjugates (ADCs), enabled by its proprietary integrated cell-free protein synthesis platform, XpressCF, and its site-specific conjugation platform, XpressCF+. It designs and develops therapeutics using the relevant and potent modalities, including ADCs, bispecific ADCs, immunostimulatory ADCs, and dual conjugate ADCs. Enabled through its XpressCF and XpressCF+ platforms, it has entered multi-target, product-focused collaborations with pharmaceutical and biotechnology companies in the field of oncology, with its ongoing relationships that include licensing to Ipsen, on an exclusive basis, the right to research, develop, manufacture and commercialize STRO-003. STRO-003 is developed for the treatment of solid tumors. Its XpressCF and XpressCF platforms supports Vaxcyte, focused on discovery and development of vaccines for the treatment and prophylaxis of infectious disease.

Webull offers Sutro Biopharma Inc stock information, including NASDAQ: STRO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, STRO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading STRO stock methods without spending real money on the virtual paper trading platform.